From July 1, 2023 to September 30, 2023, the company has repurchased 3,139,400 shares, representing 0.85% for ¥4,087.94 million. With this, the company has completed the repurchase of 8,809,300 shares, representing 2.36% for ¥11,124.4 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,614 JPY | -0.28% | +5.66% | +14.91% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.91% | 3.75B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.21% | 238B | |
+7.18% | 204B | |
-6.26% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.